|
Activating robust immunity to tumor-associated antigens:mechanisms and biology
|
5R01CA138617-05
|
$283,799
|
$283,799
|
Janssen, Edith
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
|
ZIA SC 004020
|
$2,557,725
|
$255,772
|
Berzofsky, Jay
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
2P30CA014599-38
|
$4,093,246
|
$40,932
|
LE BEAU, MICHELLE
|
UNIVERSITY OF CHICAGO
|
|
Cancer Center Support Grant
|
3P30CA014599-38S1
|
$37,500
|
$375
|
LE BEAU, MICHELLE
|
UNIVERSITY OF CHICAGO
|
|
Cancer Center Support Grant
|
3P30CA014599-38S2
|
$125,000
|
$1,250
|
LE BEAU, MICHELLE
|
UNIVERSITY OF CHICAGO
|
|
Carle Cancer Center Community Clinical Oncology Program
|
2U10CA035195-30
|
$828,213
|
$16,564
|
ROWLAND, KENDRITH
|
CARLE FOUNDATION
|
|
CCOP: Colorado Cancer Research Program
|
5U10CA067753-18
|
$1,136,278
|
$34,088
|
Sturtz, Keren
|
COLORADO CANCER RESEARCH PROGRAM, INC.
|
|
CENTRAL ILLINOIS COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA045807-28
|
$1,542,411
|
$30,848
|
WADE, JAMES
|
DECATUR MEMORIAL HOSPITAL
|
|
Chile Gallbladder Cancer Study
|
ZIA CP010218-10540
|
$322,962
|
$129,185
|
Koshiol, Jill
|
DCEG (NCI)
|
|
Clinical Interventional Studies of HIV Reservoirs
|
ZIA BC 011464
|
$1,095,816
|
$164,372
|
Maldarelli, Frank
|
CCR (NCI)
|
|
Columbus Community Clinical Oncology Program (Columbus CCOP)
|
5U10CA035261-30
|
$733,151
|
$14,663
|
KUEBLER, J
|
COLUMBUS COMMUNITY CLINICAL ONCOLOGY PRG
|
|
Community Clinical Oncology Program
|
2U10CA035199-30
|
$363,406
|
$3,634
|
GRINBLATT, DAVID
|
NORTHSHORE UNIVERSITY HEALTHSYSTEM
|
|
Community Clinical Oncology Program
|
5U10CA035431-30
|
$2,126,787
|
$42,536
|
DAKHIL, SHAKER
|
VIA CHRISTI REGIONAL MEDICAL CENTER
|
|
Control of Cytokine Gene Expression in Lymphoid/Myeloid Cells
|
ZIA BC 009283
|
$874,946
|
$874,946
|
Young, Howard
|
CCR (NCI)
|
|
Delaware/Christiana Care Community Clinical Oncology Program
|
5U10CA045418-27
|
$1,543,934
|
$15,439
|
Grubbs, Stephen
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
Developing new immunotherapies based of CD4+ T cells
|
ZIA BC 011037
|
$416,521
|
$41,652
|
Restifo, Nicholas
|
CCR (NCI)
|
|
Differentiation of Granulocytes and Macrophages
|
4R37CA022556-35
|
$216,389
|
$216,389
|
METCALF, DONALD
|
WALTER AND ELIZA HALL INST MEDICAL RES
|
|
Duluth Community Clinical Oncology Program
|
5U10CA035269-30
|
$770,073
|
$7,701
|
Nikcevich, Daniel
|
ESSENTIA INSTITUTE OF RURAL HEALTH
|
|
Eastern Cooperative Group Chair's Office
|
5U10CA086802-15
|
$524,501
|
$99,655
|
COMIS, ROBERT
|
DREXEL UNIVERSITY
|
|
EASTERN COOPERATIVE ONCOLOGY GROUP
|
3U10CA014958-38S1
|
$144,167
|
$27,392
|
Sparano, Joseph
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Eastern Cooperative Oncology Group
|
3U10CA080775-14S1
|
$43,980
|
$8,356
|
BUBLEY, GLENN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Eastern Cooperative Oncology Group
|
5U10CA049883-25
|
$261,237
|
$49,635
|
MILLER, KATHY
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Eastern Cooperative Oncology Group
|
5U10CA016116-40
|
$227,541
|
$43,233
|
FORASTIERE, ARLENE
|
JOHNS HOPKINS UNIVERSITY
|
|
Eastern Cooperative Oncology Group
|
5U10CA013650-41
|
$176,112
|
$33,461
|
habermann, thomas
|
MAYO CLINIC ROCHESTER
|
|
Eastern Cooperative Oncology Group
|
5U10CA027525-35
|
|
$0
|
GOLDSTEIN, LORI
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Eastern Cooperative Oncology Group
|
7U10CA027525-36
|
$362,721
|
$68,917
|
GOLDSTEIN, LORI
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
EASTERN COOPERATIVE ONCOLOGY GROUP
|
3U10CA015488-40S1
|
$333,233
|
$63,314
|
Luger, Selina
|
UNIVERSITY OF PENNSYLVANIA
|
|
Eastern Cooperative Oncology Group
|
5U10CA049957-25
|
$291,047
|
$55,299
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY MED CTR
|
|
Eastern Cooperative Oncology Group (Main Institution)
|
5U10CA039229-28
|
$200,536
|
$38,102
|
Kirkwood, John
|
UNIVERSITY OF PITTSBURGH
|
|
EASTERN COOPERATIVE ONCOLOGY GROUP - WISCONSIN STUDIES
|
5U10CA021076-38
|
$496,942
|
$94,419
|
Kahl, Brad
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Eastern Cooperative Oncology Group Operations Office
|
3U10CA021115-38S1
|
$139,560
|
$26,516
|
COMIS, ROBERT
|
FRONTIER SCI & TECHNOLOGY RSCH FDN, INC
|
|
Eastern Cooperative Oncology Group Operations Office
|
5U10CA021115-39
|
$9,389,476
|
$1,784,000
|
COMIS, ROBERT
|
FRONTIER SCI & TECHNOLOGY RSCH FDN, INC
|
|
Eastern Cooperative Oncology Group Studies
|
3U10CA014548-38S1
|
$334,918
|
$63,634
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
ECOG - ACRIN CCOP RESEARCH BASE GRANT - CORE
|
5U10CA037403-28
|
$3,503,729
|
$350,373
|
COMIS, ROBERT
|
DREXEL UNIVERSITY
|
|
ECOG Clinical Trials
|
5U10CA017145-38
|
$362,638
|
$68,901
|
BENSON, AL
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
ECOG Statistical Office
|
5U10CA023318-37
|
$1,894,415
|
$359,939
|
GRAY, ROBERT
|
DANA-FARBER CANCER INST
|
|
ECOG Statistical Office Data Management Grant
|
5U10CA066636-20
|
$2,152,030
|
$408,886
|
GRAY, ROBERT
|
FRONTIER SCI & TECHNOLOGY RSCH FDN, INC
|
|
EORTC HEADQUARTERS
|
4U10CA011488-43
|
$250,025
|
$5,001
|
Lacombe, Denis
|
EUROPEAN ORG/RES/TREATMENT/CANCER
|
|
Geisinger Clinical Oncology Program
|
3U10CA035448-29S1
|
$498,395
|
$4,984
|
Gorak, Edward
|
GEISINGER CLINIC
|
|
GHSU Minority-Based Community Clinical Oncology Program
|
5U10CA107586-10
|
$480,324
|
$9,606
|
Ghamande, Sharad
|
GEORGIA REGENTS UNIVERSITY
|
|
Growth Control in Multiple Myeloma
|
5P01CA055819-19
|
$3,402,629
|
$340,263
|
BARLOGIE, BART
|
UNIV OF ARKANSAS FOR MED SCIS
|
|
Gundersen Lutheran Proposal to Join the Community Clinical Oncology Program
|
5U10CA159950-03
|
$445,370
|
$44,537
|
Oettel, Kurt
|
GUNDERSEN LUTHERAN MEDICAL FOUNDATION
|
|
HALT-C Study
|
ZIA CP005782-10070
|
$90,957
|
$4,548
|
O'Brien, Thomas
|
DCEG (NCI)
|
|
Illinois Oncology Research Association Community Clinical Oncology Program
|
5U10CA035113-30
|
$852,293
|
$17,046
|
Le-Lindqwister, Nguyet
|
ONCOLOGY-HEMATOLOGY ASSOC-CENTRAL ILL
|
|
Immune reconstitution following autologous and allogeneic stem cell transplant
|
ZIC BC 010934
|
$584,855
|
$175,456
|
Hakim, Frances
|
CCR (NCI)
|
|
Immune Regulatory Roles of Suppressor Of Cytokine Signaling (SOCS) Molecules
|
ZIA BC 011215
|
$187,051
|
$149,641
|
Park, Jung-Hyun
|
CCR (NCI)
|
|
Immunology of Unique Tumor Specific Antigens
|
2R01CA037156-23A1
|
$260,385
|
$130,193
|
Schreiber, Hans
|
UNIVERSITY OF CHICAGO
|
|
Iowa Oncology Research Association
|
5U10CA035101-28
|
$747,553
|
$7,476
|
Behrens, Robert
|
IOWA ONCOLOGY RESEARCH ASSOCIATION
|
|
IP-10 Chemokine: Its Role in T Cell Recruitment and Disease
|
5R01CA069212-17
|
$362,248
|
$181,124
|
LUSTER, ANDREW
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Kalamazoo Community Clinical Oncology Program
|
2U10CA035184-28A1
|
$576,852
|
$11,537
|
LORD, RAYMOND
|
WEST MICHIGAN CANCER CENTER
|
Total relevant funding to Interferon for this search: $9,068,195
|